[go: up one dir, main page]

WO2001049660A1 - A process for preparing 3-{[3-chloro-4-(methylsulfonyl)-phenyl]methylene}-2,4-pentanedione - Google Patents

A process for preparing 3-{[3-chloro-4-(methylsulfonyl)-phenyl]methylene}-2,4-pentanedione Download PDF

Info

Publication number
WO2001049660A1
WO2001049660A1 PCT/FI2000/001150 FI0001150W WO0149660A1 WO 2001049660 A1 WO2001049660 A1 WO 2001049660A1 FI 0001150 W FI0001150 W FI 0001150W WO 0149660 A1 WO0149660 A1 WO 0149660A1
Authority
WO
WIPO (PCT)
Prior art keywords
chloro
pentanedione
methylsulfonyl
propanol
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FI2000/001150
Other languages
French (fr)
Inventor
Kari Lönnberg
Reijo Bäckström
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Oyj filed Critical Orion Oyj
Priority to GB0215787A priority Critical patent/GB2373249B/en
Priority to AU25196/01A priority patent/AU2519601A/en
Publication of WO2001049660A1 publication Critical patent/WO2001049660A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Definitions

  • the present invention relates to a process for preparing a new molecule, 3- ⁇ [3-chloro- 4-(methylsulfonyl)phenyl]methylene ⁇ -2,4-pentanedione, having a structure (I)
  • Patent application EP 0 440 324 describes substituted diketones and their use.
  • the preparation of several molecules with analogous structures to (I) has been described.
  • Eg. toluene, tetrahydrofurane, trifluoroacetic acid and 2-propanol have been mentioned as suitable solvents in the processes.
  • piperidine and acetic acid or thionyl chloride as catalysts.
  • Eg. 3-[(4- methylsulfonylphenyl)methylene]-2,4-pentanedione has been prepared in 2-propanol using thionyl chloride as a catalyst. The solution is evaporated to dryness in vacuo and the product is crystallized from toluene.
  • 3- [(3, 4- dichlorophenyl)methylene]-2,4-pentanedione is prepared using toluene as a solvent and piperidine and acetic acid as catalyst. Anyhow, none of the examples describe 3- ⁇ [3-chloro-4-(methylsulfonyl)phenyl]methylene ⁇ -2,4-pentanedione, nor the use of 2- propanol as a solvent with an amine as a catalyst in the preparation of similar compounds.
  • the object of this invention is the preparation of 3- ⁇ [3-chloro-4- (methylsulfonyl)phenyl]methylene ⁇ -2,4-pentanedione from 3-chloro-4- (methylsulfonyl)benzaldehyde (II)
  • 3-Chloro-4-(methylsulfonyl)benzaldehyde (II) can be prepared eg. from halogenated benzaldehydes, eg. 3-chloro-4-fluorobenzaldehyde or 3,4-dichlorobenzaldehyde and sodium salt of methanesulfinic acid, eg. from 3,4-dichlorobenzaldehyde and methanesulfinic sodium salt as described in example 1.
  • compound (I) is prepared by the process according to the invention, compound (II) is allowed to react with compound (III) in 2-propanol or in the mixture of 2- propanol and DMF in the presence of an amine, preferably a secondary amine and most preferably piperidine or in the presence of amine and a weak acid, preferably organic acid and most preferably acetic acid or formic acid.
  • the acid is used in proportion to amine from 0 to 4 equivalence, preferably in proportion 1 : 1.
  • 2,4- Pentanedione (compound III) is used from 1 to 5 equivalents to 3-chloro-4- (methylsulfonyl)benzaldehyde (compound II), preferably 2 to 3 equivalents.
  • 2-propanol is used 2,5 - 4,5 times the amount of DMF, preferably the ratio of DMF to 2-propanol is from 1:3 to 1 :4, most preferably 1 :3,5.
  • 3,4-Pentanedione is added to a mixture containing 3-chloro-4-(methylsulfonyl)- benzaldehyde, amine and optionally an acid in 2-propanol or in 2-propanol and DMF.
  • the mixture is stirred in ambient temperature overnight.
  • the product is separated by filtration and washed with cold 2-propanol.
  • reaction it is also possible to perform the reaction in higher temperature, about 50 - 70 °C , and use a shorter reaction time, from 1 to 10 hours. After the reaction is complete, the mixture is cooled to and the product is filtered and washed.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

3-{[3-Chloro-4-(methylsulfonyl)phenyl]methylene}-2,4-pentanedione is prepared from 3-chloro-4-(methylsulfonyl)benzaldehyde and 2,4-pentanedione using 2-propanol or 2-propanol and DMF as a solvent and an amine optionally with a weak acid as a catalyst.

Description

A PROCESS FOR PREPARING 3-{[3-CHLORO-4-(METHYLSULFONYL)- PHENYL]METHYLENE}-2,4-PENTANEDIONE
The present invention relates to a process for preparing a new molecule, 3-{ [3-chloro- 4-(methylsulfonyl)phenyl]methylene} -2,4-pentanedione, having a structure (I)
Figure imgf000002_0001
using 2-propanol or a mixture of 2-propanol and dimethylformamide (DMF) as a solvent and an amine or amine and a weak acid as a catalyst. 3-{ [3-Chloro-4- (methylsulfonyl)phenyl]methylene} -2,4-pentanedione is found to be suitable for the prevention and treatment of respiratory diseases, especially asthma.
Patent application EP 0 440 324 describes substituted diketones and their use. The preparation of several molecules with analogous structures to (I) has been described. Eg. toluene, tetrahydrofurane, trifluoroacetic acid and 2-propanol have been mentioned as suitable solvents in the processes. In addition there are used eg. piperidine and acetic acid or thionyl chloride as catalysts. Eg. 3-[(4- methylsulfonylphenyl)methylene]-2,4-pentanedione has been prepared in 2-propanol using thionyl chloride as a catalyst. The solution is evaporated to dryness in vacuo and the product is crystallized from toluene. In another example 3- [(3, 4- dichlorophenyl)methylene]-2,4-pentanedione is prepared using toluene as a solvent and piperidine and acetic acid as catalyst. Anyhow, none of the examples describe 3- { [3-chloro-4-(methylsulfonyl)phenyl]methylene} -2,4-pentanedione, nor the use of 2- propanol as a solvent with an amine as a catalyst in the preparation of similar compounds.
Accordingly, the object of this invention is the preparation of 3-{ [3-chloro-4- (methylsulfonyl)phenyl]methylene} -2,4-pentanedione from 3-chloro-4- (methylsulfonyl)benzaldehyde (II)
Figure imgf000003_0001
and 2,4-pentanedione (III)
Figure imgf000003_0002
using 2-propanol or 2-propanol and DMF as a solvent and amine or an amine and a weak acid as a catalyst. The product is recovered from the reaction mixture with high yield and purity without need of separate crystallization step.
3-Chloro-4-(methylsulfonyl)benzaldehyde (II) can be prepared eg. from halogenated benzaldehydes, eg. 3-chloro-4-fluorobenzaldehyde or 3,4-dichlorobenzaldehyde and sodium salt of methanesulfinic acid, eg. from 3,4-dichlorobenzaldehyde and methanesulfinic sodium salt as described in example 1.
When compound (I) is prepared by the process according to the invention, compound (II) is allowed to react with compound (III) in 2-propanol or in the mixture of 2- propanol and DMF in the presence of an amine, preferably a secondary amine and most preferably piperidine or in the presence of amine and a weak acid, preferably organic acid and most preferably acetic acid or formic acid. The acid is used in proportion to amine from 0 to 4 equivalence, preferably in proportion 1 : 1. 2,4- Pentanedione (compound III) is used from 1 to 5 equivalents to 3-chloro-4- (methylsulfonyl)benzaldehyde (compound II), preferably 2 to 3 equivalents. If the mixture of 2-propanol and DMF is used, 2-propanol is used 2,5 - 4,5 times the amount of DMF, preferably the ratio of DMF to 2-propanol is from 1:3 to 1 :4, most preferably 1 :3,5.
3,4-Pentanedione is added to a mixture containing 3-chloro-4-(methylsulfonyl)- benzaldehyde, amine and optionally an acid in 2-propanol or in 2-propanol and DMF. The mixture is stirred in ambient temperature overnight. The product is separated by filtration and washed with cold 2-propanol.
Alternatively the suspension of 3-chloro-4-(methylsulfonyl)benzaldehyde in 2- propanol is first warmed to about 50 - 70 °C, cooled to ambient temperature, and thereafter 2,4-pentanedione, amine and optionally an acid are added. The solution is mixed overnight. The product is separated by filtration and washed with cold 2- propanol.
It is also possible to perform the reaction in higher temperature, about 50 - 70 °C , and use a shorter reaction time, from 1 to 10 hours. After the reaction is complete, the mixture is cooled to and the product is filtered and washed.
The following example will illustrate the invention:
Example
3-chloro-4-(methylsulfonyl)benzaldehyde
To a solution containing 1.0 g of 3,4-dichlorobenzaldehyde in 45 ml of DMSO was added 1.93 g of methanesulfinic acid sodium salt with stirring at 90 °C . The solution was stirred for 6 hours at 90 °C and then poured in water. Sodium hydrogen carbonate was added to adjust the pH to about 8 and the product was extracted with ethyl acetate. The extract was evaporated to dryness in vacuo. The residue was triturated with 2-propanol, yield 1.06 g. 3- { [3-chloro-4-(methylsulfonyl)phenyl]methylene } -2,4-pentanedione
To a solution containing 2.5 g of 3-chloro-4-(methylsulfonyl)benzaldehyde, 0.13 ml of piperidine and 0.05 ml of formic acid in 70 ml of 2-propanol was added 2.6 ml of 2,4-pentanedione with stirring at 20 °C . The solution was stirred overnight at 20 °C. The product was filtrated and washed with 2-propanol, yield 2.1 g (60 %), mp. 140- 142 °C. 1H-NMR (DMSO-d6 ,400 MHz): 2.28 (s, 3H, CH3), 2.50 (s, 3H, CH3), 3.40 (s, 3H, CH3), 7.59 (dd, J=8.2Hz, 1.6Hz, 1H, ArH), 7.78 (s, 1H, CH), 7.80 (d, J=1.6Hz, 1H, ArH), 8.09 (d, J=8.2Hz, 1H, ArH).

Claims

1. A process for preparing 3- { [3-chloro-4-(methylsulfonyl)phenyl]methylene} -2,4- pentanedione from 3-chloro-4-(methylsulfonyl)benzaldehyde and 2,4- pentanedione characterized in th at the process is performed in 2-propanol and an amine is used as a catalyst.
2. A process according to claim 1 wherein dimethylformamide is added to the solvent.
3. A process according to claims 1 or 2, characterized in that the amine used is a secondary amine.
4. A process according to claim 3 characterized in that the secondary amine is piperidine.
5. A process according to any of claims 1 to 4, characterized in that weak acid is used as an additional catalyst.
6. A process according to claim 5, characterized in that the weak acid used as an additional catalyst is an organic acid.
7. A process according to claim 6, characterized in that the organic acid used is formic acid or acetic acid.
8. A process according to any one of claims 5 to 7, characterized in th at the molar ratio of amine to acid is from 0 to 1 :4.
9. A process according to claim 5 to 8, ch aracterized i n that the molar ratio of amine to acid is 1: 1.
PCT/FI2000/001150 1999-12-30 2000-12-28 A process for preparing 3-{[3-chloro-4-(methylsulfonyl)-phenyl]methylene}-2,4-pentanedione Ceased WO2001049660A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0215787A GB2373249B (en) 1999-12-30 2000-12-28 A process for preparing 3-{[3-chloro-4-(methylsulfonyl)-phenyl]methylene}-2,4-pentanedione
AU25196/01A AU2519601A (en) 1999-12-30 2000-12-28 A process for preparing 3-((3-chloro-4-(methylsulfonyl)-phenyl)methylene)-2,4- pentanedione

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI992819 1999-12-30
FI19992819 1999-12-30

Publications (1)

Publication Number Publication Date
WO2001049660A1 true WO2001049660A1 (en) 2001-07-12

Family

ID=8555836

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FI2000/001150 Ceased WO2001049660A1 (en) 1999-12-30 2000-12-28 A process for preparing 3-{[3-chloro-4-(methylsulfonyl)-phenyl]methylene}-2,4-pentanedione

Country Status (3)

Country Link
AU (1) AU2519601A (en)
GB (1) GB2373249B (en)
WO (1) WO2001049660A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103613488A (en) * 2013-11-25 2014-03-05 格林生物科技股份有限公司 Preparation method of 2-methyl-2-pentenal

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357403A2 (en) * 1988-09-01 1990-03-07 Orion-Yhtymà„ Oy Substituted beta-diketones
EP0440324A2 (en) * 1990-02-02 1991-08-07 Orion-Yhtymà„ Oy Substituted beta-diketones and their use
WO2000001667A1 (en) * 1998-07-01 2000-01-13 Orion Corporation SUBSTITUTED β-DIKETONES AND THEIR USE

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357403A2 (en) * 1988-09-01 1990-03-07 Orion-Yhtymà„ Oy Substituted beta-diketones
EP0440324A2 (en) * 1990-02-02 1991-08-07 Orion-Yhtymà„ Oy Substituted beta-diketones and their use
WO2000001667A1 (en) * 1998-07-01 2000-01-13 Orion Corporation SUBSTITUTED β-DIKETONES AND THEIR USE

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103613488A (en) * 2013-11-25 2014-03-05 格林生物科技股份有限公司 Preparation method of 2-methyl-2-pentenal
CN103613488B (en) * 2013-11-25 2015-09-23 格林生物科技股份有限公司 A kind of preparation method of 2-methyl-2-pentenal serving

Also Published As

Publication number Publication date
GB2373249B (en) 2004-04-14
GB2373249A (en) 2002-09-18
GB0215787D0 (en) 2002-08-14
AU2519601A (en) 2001-07-16

Similar Documents

Publication Publication Date Title
EP3166927B1 (en) Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids
EP1274686B1 (en) Process for preparing 2-(4-chlorobenzolamino) -3- 2(1h) -quinolinon-4-yl proprionic acid
JP2003533497A (en) Method for producing aniline compound
CN112272665A (en) Process for preparing sitagliptin
JP2904038B2 (en) Process for producing 4,6-diaminoresorcinol and its precursor
WO2001049660A1 (en) A process for preparing 3-{[3-chloro-4-(methylsulfonyl)-phenyl]methylene}-2,4-pentanedione
CN114573555A (en) Preparation method of compound for treating migraine
US4014896A (en) Catalytic dehydrogenation process for the preparation of 3,4,5-trisubstituted pyrazoles
NZ213473A (en) Process for preparing quinazoline-2,4-diones
JP2003506312A (en) Meta-nitrophenol derivative and method for producing the same
JP3721540B2 (en) Pyrrolidine derivatives
US6011178A (en) Process for the preparation of 2-amino-4,5,3',4'-tetramethoxybenzophenone
CN115197086B (en) Preparation method of difluoromethoxy-containing m-diamide compound
JPH072742A (en) New production method of 4-amino-3-methyl-n-ethyl-n-(beta-hydroxyethyl)aniline sulfuric acid salt
JPH09188662A (en) Method for producing sulfonic acid amide compound
JPH06247918A (en) Preparation of phenylbenzamide derivative
KR101302083B1 (en) Method for the production of substituted 2-alkoxycarbonyl-3-aminothiophenes
JPH051023A (en) Process for producing alkane sulfone anilide derivative
JPH0140833B2 (en)
JP4032825B2 (en) Method for producing 3,4-dihydroxybenzonitrile
JPH06211824A (en) Preparation of ranitidine
JPS63303958A (en) Production of 2-amino-4,6-dichloro-5-alkylphenol
JP4267107B2 (en) Pyridine derivative and method for producing the same
JP4114911B2 (en) Method for producing 4-hydroxybenzenesulfonanilide
JP2004504261A (en) Production of hydrogenated primary amines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: GB

Ref document number: 200215787

Kind code of ref document: A

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP